RxDoctor Payments Data

Jane Yoo, MD

MOHS-Micrographic Surgery · New York, NYNPI 1447571518

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by AbbVie at 27.9% of the total. 2025 is the largest year on record at $19,206, more than ten times the $806 reported in 2019. Among mohs-micrographic surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$41,763in general payments, 2019–2025

Across 155 payments — averaging $269.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$12K
  • Incyte Corporation$12K
  • Lumenis BE Inc$8K
  • Sanofi$3K
  • Arcutis Biotherapeutics, Inc.$2K
  • Biofrontera Inc.$2K
  • plus $4K from 13 others

What the payments were for

  • Consulting fees$23,73257%
  • Travel & lodging$4,43111%
  • Food & beverage$13,45332%
  • Education$1040%
  • Gifts$440%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,763 in reported general payments places this provider in the 90th percentile of 75 mohs-micrographic surgery providers in New York.

See all mohs-micrographic surgery providers in New York

Medicare billing

Part B allowed, 2024
$10,166
Medicare patients
30
Services billed
103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole11$211

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →